An Adenylyl Cyclase-mAKAPbeta Signaling Complex Regulates CAMP Levels in Cardiac Myocytes

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2009 Jul 4

PMID 19574217

Citations 81

Authors

Michael S Kapiloff

Leslie A Piggott

Rachna Sadana

Jinliang Li

Lorena A Heredia

Edward Henson

Riad Efendiev

Carmen W Dessauer

Affiliations

Soon will be listed here.

Abstract

Protein kinase A-anchoring proteins (AKAPs) play important roles in the compartmentation of cAMP signaling, anchoring protein kinase A (PKA) to specific cellular organelles and serving as scaffolds that assemble localized signaling cascades. Although AKAPs have been recently shown to bind adenylyl cyclase (AC), the functional significance of this association has not been studied. In cardiac myocytes, the muscle protein kinase A-anchoring protein beta (mAKAPbeta) coordinates cAMP-dependent, calcium, and MAP kinase pathways and is important for cellular hypertrophy. We now show that mAKAPbeta selectively binds type 5 AC in the heart and that mAKAPbeta-associated AC activity is absent in AC5 knock-out hearts. Consistent with its known inhibition by PKA phosphorylation, AC5 is inhibited by association with mAKAPbeta-PKA complexes. AC5 binds to a unique N-terminal site on mAKAP-(245-340), and expression of this peptide disrupts endogenous mAKAPbeta-AC association. Accordingly, disruption of mAKAPbeta-AC5 complexes in neonatal cardiac myocytes results in increased cAMP and hypertrophy in the absence of agonist stimulation. Taken together, these results show that the association of AC5 with the mAKAPbeta complex is required for the regulation of cAMP second messenger controlling cardiac myocyte hypertrophy.

Citing Articles

Nanodomain cAMP signaling in cardiac pathophysiology: potential for developing targeted therapeutic interventions.

Zaccolo M, Kovanich D Physiol Rev. 2024; 105(2):541-591.

PMID: 39115424 PMC: 7617275. DOI: 10.1152/physrev.00013.2024.

Adenylyl cyclase isoforms 5 and 6 in the cardiovascular system: complex regulation and divergent roles.

Maghsoudi S, Shuaib R, Van Bastelaere B, Dakshinamurti S Front Pharmacol. 2024; 15:1370506.

PMID: 38633617 PMC: 11021717. DOI: 10.3389/fphar.2024.1370506.

Protein phosphatase 2A anchoring disruptor gene therapy for familial dilated cardiomyopathy.

Li X, Li J, Samuelsson A, Thakur H, Kapiloff M Mol Ther Methods Clin Dev. 2024; 32(2):101233.

PMID: 38572067 PMC: 10988123. DOI: 10.1016/j.omtm.2024.101233.

The MEF2A transcription factor interactome in cardiomyocytes.

Moustafa A, Hashemi S, Brar G, Grigull J, Ng S, Williams D Cell Death Dis. 2023; 14(4):240.

PMID: 37019881 PMC: 10076289. DOI: 10.1038/s41419-023-05665-8.

POPDC1 scaffolds a complex of adenylyl cyclase 9 and the potassium channel TREK-1 in heart.

Baldwin T, Li Y, Marsden A, Rinne S, Garza-Carbajal A, Schindler R EMBO Rep. 2022; 23(12):e55208.

PMID: 36254885 PMC: 9724675. DOI: 10.15252/embr.202255208.

References

Okumura S, Vatner D, Kurotani R, Bai Y, Gao S, Yuan Z . Disruption of type 5 adenylyl cyclase enhances desensitization of cyclic adenosine monophosphate signal and increases Akt signal with chronic catecholamine stress. Circulation. 2007; 116(16):1776-83. DOI: 10.1161/CIRCULATIONAHA.107.698662. View

Katsushika S, Chen L, Kawabe J, Nilakantan R, Halnon N, Homcy C . Cloning and characterization of a sixth adenylyl cyclase isoform: types V and VI constitute a subgroup within the mammalian adenylyl cyclase family. Proc Natl Acad Sci U S A. 1992; 89(18):8774-8. PMC: 50003. DOI: 10.1073/pnas.89.18.8774. View

Piggott L, Bauman A, Scott J, Dessauer C . The A-kinase anchoring protein Yotiao binds and regulates adenylyl cyclase in brain. Proc Natl Acad Sci U S A. 2008; 105(37):13835-40. PMC: 2544540. DOI: 10.1073/pnas.0712100105. View

Belcheva M, Gucker S, Chuang D, Clark W, Jefcoat L, McHale R . Modulation of opioid binding associated with nuclear matrix and nuclear membranes of NG108-15 cells. J Pharmacol Exp Ther. 1995; 274(3):1513-23. View

Dessauer C, Chen-Goodspeed M, Chen J . Mechanism of Galpha i-mediated inhibition of type V adenylyl cyclase. J Biol Chem. 2002; 277(32):28823-9. DOI: 10.1074/jbc.M203962200. View

Michel J, Dodge K, Wong W, Mayer N, Langeberg L, Scott J . PKA-phosphorylation of PDE4D3 facilitates recruitment of the mAKAP signalling complex. Biochem J. 2004; 381(Pt 3):587-92. PMC: 1133866. DOI: 10.1042/BJ20040846. View

Yan L, Vatner D, OConnor J, Ivessa A, Ge H, Chen W . Type 5 adenylyl cyclase disruption increases longevity and protects against stress. Cell. 2007; 130(2):247-58. DOI: 10.1016/j.cell.2007.05.038. View

Okumura S, Takagi G, Kawabe J, Yang G, Lee M, Hong C . Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload. Proc Natl Acad Sci U S A. 2003; 100(17):9986-90. PMC: 187910. DOI: 10.1073/pnas.1733772100. View

Bauman A, Soughayer J, Nguyen B, Willoughby D, Carnegie G, Wong W . Dynamic regulation of cAMP synthesis through anchored PKA-adenylyl cyclase V/VI complexes. Mol Cell. 2006; 23(6):925-31. PMC: 3941446. DOI: 10.1016/j.molcel.2006.07.025. View

10.

Sadana R, Dessauer C . Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies. Neurosignals. 2008; 17(1):5-22. PMC: 2790773. DOI: 10.1159/000166277. View

11.

Boivin B, Lavoie C, Vaniotis G, Baragli A, Villeneuve L, Ethier N . Functional beta-adrenergic receptor signalling on nuclear membranes in adult rat and mouse ventricular cardiomyocytes. Cardiovasc Res. 2006; 71(1):69-78. DOI: 10.1016/j.cardiores.2006.03.015. View

12.

Pare G, Bauman A, McHenry M, Michel J, Dodge-Kafka K, Kapiloff M . The mAKAP complex participates in the induction of cardiac myocyte hypertrophy by adrenergic receptor signaling. J Cell Sci. 2005; 118(Pt 23):5637-46. DOI: 10.1242/jcs.02675. View

13.

Dodge K, Khouangsathiene S, Kapiloff M, Mouton R, HILL E, Houslay M . mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. EMBO J. 2001; 20(8):1921-30. PMC: 125429. DOI: 10.1093/emboj/20.8.1921. View

14.

Pare G, Easlick J, Mislow J, McNally E, Kapiloff M . Nesprin-1alpha contributes to the targeting of mAKAP to the cardiac myocyte nuclear envelope. Exp Cell Res. 2005; 303(2):388-99. DOI: 10.1016/j.yexcr.2004.10.009. View

15.

Michel J, Townley I, Dodge-Kafka K, Zhang F, Kapiloff M, Scott J . Spatial restriction of PDK1 activation cascades by anchoring to mAKAPalpha. Mol Cell. 2005; 20(5):661-72. DOI: 10.1016/j.molcel.2005.10.013. View

16.

Yamamoto S, Kawamura K, James T . Intracellular distribution of adenylate cyclase in human cardiocytes determined by electron microscopic cytochemistry. Microsc Res Tech. 1998; 40(6):479-87. DOI: 10.1002/(SICI)1097-0029(19980301)40:6<479::AID-JEMT8>3.0.CO;2-K. View

17.

McConnachie G, Langeberg L, Scott J . AKAP signaling complexes: getting to the heart of the matter. Trends Mol Med. 2006; 12(7):317-23. DOI: 10.1016/j.molmed.2006.05.008. View

18.

Fink M, Zakhary D, Mackey J, Desnoyer R, Apperson-Hansen C, Damron D . AKAP-mediated targeting of protein kinase a regulates contractility in cardiac myocytes. Circ Res. 2001; 88(3):291-7. DOI: 10.1161/01.res.88.3.291. View

19.

Dodge-Kafka K, Soughayer J, Pare G, Michel J, Langeberg L, Kapiloff M . The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature. 2005; 437(7058):574-8. PMC: 1636584. DOI: 10.1038/nature03966. View

20.

Gao T, Puri T, Gerhardstein B, Chien A, Green R, Hosey M . Identification and subcellular localization of the subunits of L-type calcium channels and adenylyl cyclase in cardiac myocytes. J Biol Chem. 1997; 272(31):19401-7. DOI: 10.1074/jbc.272.31.19401. View